Area of research
Psychiatry and Mental health · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Medicine, Dravet syndrome, Placebo, Cannabidiol, Epilepsy, and Tolerability.
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo‐controlled clinical trial
Severe communication delays are independent of seizure burden and persist despite contemporary treatments in <i>SCN1A</i>+ Dravet syndrome: Insights from the <scp>ENVISION</scp> natural history study
NCKAP1 Disruptive Variants Lead to a Neurodevelopmental Disorder with Core Features of Autism
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Stiripentol in <scp>D</scp>ravet syndrome: Results of a retrospective <scp>U</scp>.<scp>S</scp>. study